Local infusion clinic, Brookwell Health, is helping fight the COVID-19 pandemic by offering Bamlanivimab, a neutralizing antibody therapy.
“COVID-19 has severely impacted many families in Hamblen and the surrounding counties. We have been seeking ways we can help anyone who contracts COVID-19 – especially those who are most vulnerable and likely to have difficulties with the disease. We are thrilled to be able to offer this therapy as a way to prevent severe complications.” said Dr. Donna Dillard, medical director of Brookwell Health. “There is some indication that Bamlanivimab – and potentially other monoclonal antibodies – can reduce symptoms of COVID-19. Early intervention is the key to countering the potential devastating impact of the virus.”
Lilly’s Bamlanivimab is authorized for emergency use by the U.S. Food and Drug Administration for the treatment of mild to moderate COVID-19 in high-risk patients.
Brookwell Health is contracted with most insurers and is partnering with the Tennessee Department of Health to offer this treatment to families in and around the Lakeway Area.
Since opening in late 2020, Brookwell Health has made an immediate impact in the community
According to industry research, the cost of an infusion therapy provided in an outpatient setting can save patients and insurers around 50 percent or more on the typical cost of an infusion provided in a hospital setting.
“Our patients are so much more comfortable because our clinic feels more like a spa.” added Madison Heidel, nurse practitioner at Brookwell Health. “We provide snacks, drinks and have private and semi-private suites to help our patients feel calm and relaxed. It is really important that our patients know we care about them.”
Brookwell Health also offers infusion treatments for Crohn’s Disease, Ulcerative Colitis, Multiple Sclerosis, Lupus, Psoriasis, Rheumatoid Arthritis and other diseases.
Anyone needing infusion treatments should speak with their medical provider or call Brookwell Health at 423-616-9757.